Skip to main content

PRF Technologies Ltd.

corporate_fare Company Profile

PRF Technologies Ltd.

PainReform Ltd., a clinical stage specialty pharmaceutical company, focuses on the reformulation of established therapeutics and provides an extended period of post-surgical pain relief in Israel. It develops PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia, as well as in Phase 3 clinical trial for pain treatment of patients undergoing bunionectomy and pain treatment of hernia repair operations. The company was incorporated in 2007 and is based in Tel Aviv, Israel.

Exchange: NASDAQSector: Life Sciences

show_chartPrice Chart

Loading chart...

feed PRFX - Latest Insights

PRFX
Apr 28, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
PRFX
Mar 27, 2026, 8:30 AM EDT
Filing Type: 6-K
Importance Score:
8
PRFX
Mar 27, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
PRFX
Mar 17, 2026, 8:30 AM EDT
Source: GlobeNewswire
Importance Score:
8
PRFX
Feb 18, 2026, 9:38 AM EST
Filing Type: 6-K
Importance Score:
8
PRFX
Feb 11, 2026, 8:54 AM EST
Filing Type: 6-K
Importance Score:
8
PRFX
Feb 03, 2026, 4:16 PM EST
Filing Type: 6-K
Importance Score:
8
PRFX
Jan 20, 2026, 9:07 AM EST
Filing Type: 6-K
Importance Score:
7
PRFX
Jan 15, 2026, 4:10 PM EST
Filing Type: 6-K
Importance Score:
8
PRFX
Jan 12, 2026, 9:10 AM EST
Filing Type: 6-K
Importance Score:
7
PRFX
Jan 07, 2026, 4:15 PM EST
Filing Type: 6-K
Importance Score:
8
PRFX
Jan 05, 2026, 9:09 AM EST
Filing Type: 6-K
Importance Score:
7